Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Sarina Mariano

Physician Assistant Amherst, NY Physician Assistant

NPI 1851706857 CMS profile 10490887

3980 Sheridan Dr, Amherst, NY 14226

Open in the dashboard

General payments

$2,112

158 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarina Mariano of Amherst, NY is reported in the CMS Open Payments database as having received $2,112 across 158 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,024 157
2021 General $88 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarina Mariano
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Sarina Mariano were reported at $2,024. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Sarina Mariano Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $88 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $2,024 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $449 40 payments
  2. Tonix Pharmaceuticals, Inc. $279 32 payments
  3. Lundbeck LLC $255 15 payments
  4. Teva Pharmaceuticals USA, Inc. $230 16 payments
  5. Currax Pharmaceuticals LLC $224 25 payments
  6. Pfizer Inc. $144 8 payments
  7. Axsome Therapeutics, Inc. $116 5 payments
  8. ACADIA Pharmaceuticals Inc $88 1 payment
  9. Lilly USA, LLC $70 4 payments
  10. Averitas Pharma Inc. $63 3 payments
  11. Other $196 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,112 158 payments
Products named General payments · program years 2021–2025
  1. UBRELVY $361 32 payments
  2. QULIPTA $341 34 payments
  3. ZEMBRACE SYMTOUCH $279 32 payments
  4. VYEPTI $255 15 payments
  5. AJOVY $230 16 payments
  6. CONTRAVE $224 25 payments
  7. ONZETRA XSAIL $224 25 payments
  8. NURTEC ODT $144 8 payments
  9. ZAVZPRET $144 8 payments
  10. Symbravo $116 5 payments
  11. Other $535 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 72 drugs

Part D claims

2,723

Median for Physician Assistant: 241

Drug cost

$137,032

Median for Physician Assistant: $4,110

Branded share of claims

16.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 89 $42,922
Xarelto Rivaroxaban Brand 36 $20,904
Rexulti Brexpiprazole Brand 11 $13,779
Jardiance Empagliflozin Brand 18 $11,146
Myrbetriq Mirabegron Brand 20 $9,124
Linzess Linaclotide Brand 12 $6,399
Memantine Hcl Generic 84 $1,872
Memantine Hcl Er Memantine Hcl Brand 22 $1,862
Atorvastatin Calcium Generic 151 $1,614
Bumetanide Generic 61 $1,471

The 10 drugs with the highest cost, of 72 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$28,636

Medicare's payments for the services billed

Medicare patients

64

Average age 87

Services billed

450

44 women, 20 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 70%
Alzheimer's or dementia 70%
Arthritis 53%
Depression 34%
Atrial fibrillation 31%
Ischemic heart disease 30%
Osteoporosis 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record